Aarti Pharmalabs Limited (NSEI: AARTIPHARM)
Health Care · Pharmaceuticals · IN
Rs855.50
-11.67% today · +3.7% 1Y
Aarti Pharmalabs Limited (NSEI: AARTIPHARM) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $801.57M and employs 2,421 people.
Over the last twelve months the share price has gained 3.7%, trading between 585.00 and 1.00K.
Tweenvest scores Aarti Pharmalabs Limited across four factors: quality 68/100, value 26/100, dividend 48/100. Its strongest factor is quality.
AARTIPHARM price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $801.57M
- Revenue (TTM)
- $208.25M
- P/E
- 37.92
- EPS
- 22.56
- Dividend yield
- 0.41%
- Beta (5Y)
- 0.25
- 52-week high
- Rs1,002.40
- 52-week low
- Rs585.00
- Avg volume (3M)
- —
- Shares outstanding
- 90.68M
- Employees
- 2,421
- Next earnings
- —
About Aarti Pharmalabs Limited
Aarti Pharmalabs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. The company offers active pharmaceutical ingredients for various therapeutic areas, such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous system agent, skincare, overactive bladder, calcimimetic, decongestant, anti-thalassaemic, analgesic, and ophthalmologic medications. It also provides contract development and manufacturing services for drug substance projects. In addition, the company offers intermediates; xanthine derivatives, including caffeine, theophylline anhydrous, aminophylline, etophylline, and theophylline; and acid and allied products, including sulphuric acid, sulphur trioxide, oil, dimethyl sulphate, diethyl sulphate, and sodium vinyl sulfonate. The company was formerly known as Aarti Organics Limited. Aarti Pharmalabs Limited was incorporated in 2019 and is headquartered in Mumbai, India.
- ISIN
- INE0LRU01027
- Founded
- 2019
- Listed since
- Feb 3, 2023
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Hunan Jiudian Pharmaceutical Co., Ltd.SZSE: 300705 | $828.42M | CN¥11.23 | +2.93% |
| Jiangsu Jibeier Pharmaceutical Co., Ltd.SHSE: 688566 | $824.45M | CN¥27.46 | -0.94% |
| China Traditional Chinese Medicine Holdings Co. LimitedSEHK: 570 | $814.96M | HK$1.27 | +3.25% |
| Sichuan Goldstone Asia Pharmaceutical Inc.SZSE: 300434 | $807.31M | CN¥13.46 | +4.18% |
| Beijing Beilu Pharmaceutical Co., Ltd.SZSE: 300016 | $795.49M | CN¥9.16 | -4.18% |
| Hubei Biocause Heilen Pharmaceutical Co., Ltd.SZSE: 301211 | $794.91M | CN¥12.75 | +0.39% |
| Luoxin Pharmaceuticals Group Stock Co., Ltd.SZSE: 002793 | $794.00M | CN¥4.89 | +1.45% |
| Shouyao Holdings (Beijing) Co., LTD.SHSE: 688197 | $788.44M | CN¥35.51 | -5.81% |
Figures last refreshed Oct 11, 2026.